Autoimmune Hepatitis Subtypes - An Insight

What Is Autoimmune Hepatitis?

A chronic inflammatory liver condition called autoimmune hepatitis is characterized by the immune system wrongly targeting the liver cells, which results in inflammation and liver damage. Because the immune system, intended to defend against dangerous things like viruses and bacteria, mistakenly recognizes the liver cells as alien and mounts an immunological attack against them, it is seen as an autoimmune condition.

Autoimmune hepatitis is thought to be caused by an interaction of genetic and environmental factors, while its specific etiology is yet unknown. Women are more likely to experience it than men, and people with autoimmune diseases in the family are more prone to it.

What Are the Subtypes of Autoimmune Hepatitis?

These subtypes of autoimmune hepatitis are as follows:

• Autoimmune Hepatitis Type 1: This subtype makes up between 80 to 90 percent of all instances of autoimmune hepatitis, making it the most prevalent. Any age can experience it, but women are more likely to it. Antinuclear antibodies (ANAs) and smooth muscle antibodies (SMAs) are autoantibodies that are detected in the blood in type 1 autoimmune hepatitis. Anti-soluble liver antigen (anti-SLA) and anti-liver kidney microsome type 1 (anti-LKM-1) autoantibodies may also be present. Type 1 diabetes, autoimmune thyroiditis, and ulcerative colitis are frequently found in patients with type 1 AIH.

• Autoimmune Hepatitis Type 2: This subtype mostly affects children and young people and is less prevalent, accounting for approximately 10–20 percent of cases. Anti-liver cytoplasmic antibody type 1 (anti-LC1) autoantibodies are a defining feature of type 2 autoimmune hepatitis. These antibodies target kidney and liver microsomes in particular. Type 2 AIH does not share symptoms with other autoimmune disorders like type 1 AIH does.

It is vital to remember that there is another, less well-known subtype of autoimmune hepatitis termed type 3 AIH. Type 3 AIH is not widely recognized, and it lacks the precise autoantibodies or clinical characteristics that would allow type 1 or type 2 AIH to be distinguished from type 3 AIH. Research is still being done to learn more about this subtype and its distinctive traits.

To precisely identify the subtype, people who have autoimmune hepatitis must have to go through medical assessments, which may include blood testing, imaging tests, and liver biopsies. Treatment choices, including the use of immunosuppressive drugs like corticosteroids and other immunomodulatory medicines, can be influenced by the specific subtype.

What Are the Symptoms of Autoimmune Hepatitis?

The symptoms of autoimmune hepatitis can vary in severity and may include:

• Fatigue: Continual fatigue or a lack of energy is a common sign of autoimmune hepatitis.

• Jaundice: Bilirubin is a yellow pigment produced when liver cells are injured and manifests as a yellowing of the skin and eyes causing jaundice.

• Abdominal Discomfort: Uncomfortable feeling in the upper right side of the abdomen, which is where the liver is located, in certain people.

• Enlarged Liver or Spleen: An increase in the size of the liver or spleen can cause abdominal discomfort or a sense of fullness.

• Dark Urine: The urine may appear darker than usual due to the presence of bilirubin.

• Pale or Gray-colored Stools: Stools may become pale or gray in color due to a reduction in the release of bile by the liver.

• Loss of Appetite: Autoimmune hepatitis can develop a loss of appetite, leading to unintended weight loss.

• Nausea and Vomiting: Some individuals may experience nausea sensation and vomiting, especially if the disease is advanced.

• Joint Pain: Joint pain and stiffness resembling arthritis can occur in some cases of autoimmune hepatitis.

• Itchy Skin: Itching, also known as pruritus, can be a symptom of liver dysfunction and may occur in autoimmune hepatitis.

It is imperative to remember that not everyone will have the same symptoms, and some people may not have any symptoms at all. It is vital to speak with a physician for a comprehensive diagnosis and management if they think they might have autoimmune hepatitis.

What Is the Diagnosis of Autoimmune Hepatitis?

The diagnosis of autoimmune hepatitis involves a combination of clinical evaluation, laboratory tests, imaging studies, and sometimes a liver biopsy.

• Clinical Evaluation: A thorough medical history and physical examination are conducted to assess symptoms, risk factors, and signs of liver dysfunction.

• Laboratory Tests: Blood tests are performed to evaluate liver function, detect autoantibodies, and rule out other liver diseases. The following tests are commonly used:

• Liver Function Tests (LFTs): These include measuring liver enzymes like alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), and bilirubin.

• Autoantibodies: Specific autoantibodies associated with autoimmune hepatitis, such as antinuclear antibodies (ANA), anti-smooth muscle antibodies (ASMA), and anti-liver/kidney microsomal antibodies (anti-LKM), can be detected.

• Immunoglobulin Levels: Elevated levels of certain immunoglobulins, particularly immunoglobulin G (IgG), are often seen in autoimmune hepatitis.

• Imaging Studies: Imaging techniques such as ultrasound, computed tomography (CT) scan, or magnetic resonance imaging (MRI) may be used to assess the liver's size and structure and rule out other liver diseases or complications.

• Liver Biopsy: A liver biopsy is considered the gold standard for confirming the diagnosis of autoimmune hepatitis. It involves obtaining a small sample of liver tissue using a needle for microscopic examination. The biopsy helps assess the severity of inflammation, the degree of fibrosis or cirrhosis and rule out other liver diseases.

The existence and severity of autoimmune hepatitis are assessed using several of these diagnostic techniques. A healthcare expert should be consulted for a correct diagnosis and the best course of treatment.

What Is the Management of Both Types of Autoimmune Hepatitis?

The management of both types involves similar approaches, although there are some differences in treatment strategies. The following is the management of both types of autoimmune hepatitis:

Type 1 Autoimmune Hepatitis:

• Corticosteroids: High-dose corticosteroids, including Prednisone or Prednisolone, are the first line of treatment for type 1 autoimmune hepatitis. These drugs aid in reducing liver inflammation and immune response suppression.

• Immunosuppressants: Immunosuppressive drugs like Azathioprine may be added if corticosteroids alone are insufficient to control the disease or reduce side effects. To improve sickness control, Azathioprine is frequently used with corticosteroids.

• Maintenance Therapy: The dosage of corticosteroids and immunosuppressants may be gradually decreased if the condition is under control. To prevent illness return, maintenance therapy using lower doses of these drugs is typically continued for a long time, frequently indefinitely.

Type 2 Autoimmune Hepatitis:

• Prednisone and Azathioprine: Type 2 autoimmune hepatitis is generally treated with a combination of Prednisone and Azathioprine. High-dose Prednisone is used initially to control liver inflammation, followed by Azathioprine to maintain disease remission.

• Budesonide: In some cases, particularly in children, Budesonide (a type of corticosteroid) may be used as an alternative to Prednisone due to its favorable side effect profile.

• Monitoring: Regular monitoring of liver enzymes, autoantibodies, and liver function is essential to assess treatment response and adjust medication dosages accordingly.

Additional Considerations for Both Types:

• Supportive Care: It is essential to treat any symptoms or side effects, like exhaustion, jaundice, or ascites. Dietary changes, hydration control, and the use of supportive drugs may all be necessary for this.

• Follow-up: These visits are necessary for patients with autoimmune hepatitis in order to monitor liver function, modify drug dosages, and evaluate the course of the disease as a whole.

• Liver Transplantation: Liver transplantation may be a life-saving option in severe autoimmune hepatitis patients that do not improve with medical therapy or advance to end-stage liver disease.

Conclusion:

It is crucial for individuals with autoimmune hepatitis to work closely with a hepatologist or gastroenterologist experienced in managing autoimmune liver diseases to develop an individualized treatment plan based on their specific needs and disease severity. The cause of the ongoing liver inflammation known as autoimmune hepatitis is uncertain. Corticosteroids are usually effective for patients. In adverse cases, liver transplantation is suggested.